Experimental Medicine and
Immunotherapeutics
ACCI, Level 3, Box 98
Addenbrooke’s Hospital
Hills Road
Cambridge, CB2 0QQ
As of 26th Sep 2023, we are pleased to confirm final approvals have been received from the Medicines and Healthcare products Regulatory Agency (MHRA), the Research Ethics Committee (REC), and Health Research Authority (HRA) for the OPACE trial to proceed. What happens next? Following approvals, we can start initiating and activating sites to begin […]